Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1052 of 1,261
  1. US 7419989

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  2. US 7420045

    IAPs associated cell cycle proteins, compositions and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  3. US 7420084

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  4. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  5. US 7419991

    3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

    PTC THERAPEUTICS, INC. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  6. US 7419957

    Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  7. US 7419983

    Gonadotropin-releasing hormone receptor antagonists and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  8. US 7419956

    Isolated physiologically active peptide and use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  9. EP 1959855

    BEHANDLUNG VON BENIGNER PROSTATAHYPERPLASIE MIT EINEM FOTOSENSIBILISATOR UND LASERABLATION

    CERAMOPTEC GMBH [DE] · Granted Aug 27, 2008 · Expires Aug 22, 2028

    granted
  10. US 7417165

    Crystalline forms of pregabalin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  11. US 7417136

    Nucleic acid vaccines for prevention of flavivirus infection

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  12. US 7417059

    Substituted aromatic-ring compounds, process for producing the same and use

    Takeda Pharmaceutical Company Limited · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  13. US 7417134

    IL-1 receptor based cytokine traps and method of using

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  14. US 7417113

    PSCA: prostate stem cell antigen and uses thereof

    The Regents of the University of California · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  15. US 7417070

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  16. US 7416724

    Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  17. US 7417029

    Prodrug of an ice inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  18. US 7416741

    Copper lowering treatment of inflammatory and fibrotic diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  19. US 7417044

    Tadalafil having a large particle size and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  20. US 7417037

    Compositions and methods of treatment for inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  21. US 7416878

    Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments

    The United States of America as represented by the Secretary of the Army · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  22. US 7413781

    Gels for encapsulation of biological materials

    The Board of Regents of the University of Texas System · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  23. US 7414035

    hKIS composition and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  24. US 7414037

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    The Regents of the University of California · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.